Atlas Trials

Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

Clinical trial NCT00095563 · COMPLETED

Trial details

NCT number
NCT00095563
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
High-grade Salivary Gland CarcinomaHigh-grade Salivary Gland Mucoepidermoid CarcinomaLow-grade Salivary Gland CarcinomaLow-grade Salivary Gland Mucoepidermoid CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Salivary Gland CancerSalivary Gland Acinic Cell TumorSalivary Gland AdenocarcinomaSalivary Gland Adenoid Cystic CarcinomaSalivary Gland Malignant Mixed Cell Type Tumor
Start date
2004-09-01
Primary completion
2009-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.